Sterling Pharma Solutions Lauches after MBO

10.03.16

Cook will serve as chief executive officer

Sterling Pharma Solutions has formed as an independent CDMO following a management buyout of the UK-based Dudley site, which has been operating for 47 years and is among the UK’s largest providers of pharmaceutical API development and manufacturing services.
 
Formerly operating as Shasun Pharma Solutions within Strides Shasun, the process of divesting the business to the current management team was completed in September 2016.
 
The newly divested business has been rebranded and launched as Sterling Pharma Solutions, which specializes in API development and manufacturing services to support global pharma companies across the product lifecycle.
 
Kevin Cook, who joined the Dudley site in 1993, will serve as chief executive officer. He said, “We are delighted to complete the MBO and excited about building a global API services business with roots in the north east of England. Our offering is compelling as we can take projects from proof of concept to commercial scale manufacture all on one site. We also have the capabilities to handle the most hazardous chemical processes safely."